GreenLight XPS for treating benign prostatic hyperplasia (update of MTG29)
Closed for comments This consultation ended on at Request commenting lead permission
5 Committee members and NICE project team
Committee members
This topic was considered by NICE's medical technologies advisory committee, which is a standing advisory committee of NICE.
Committee members are asked to declare any interests in the technology to be appraised. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.
The minutes of the medical technologies advisory committee, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.
NICE project team
Each medical technologies guidance topic is assigned to a team consisting of 1 or more health technology assessment analysts (who act as technical leads for the topic), a health technology assessment adviser and a project manager.
Samantha Baskerville and Amy Barr
Health technology assessment analysts
Rebecca Brookfield and Ying-Ying Wang
Health technology assessment advisers
Victoria Fitton
Project manager
ISBN: [to be added at publication]
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions
Question on Consultation
Question on Consultation
Question on Consultation
Question on Consultation